O'Rourke F, Soons K, Flaumenhauft R, Watras J, Baio-Larue C, Matthews E, Feinstein M B
Department of Pharmacology, University of Connecticut Health Center, Farmington 06032.
Biochem J. 1994 Jun 15;300 ( Pt 3)(Pt 3):673-83. doi: 10.1042/bj3000673.
Ins(1,4,5)P3-induced Ca2+ release from platelet membrane vesicles was blocked by apamin, a selective inhibitor of low-conductance Ca(2+)-activated K+ channels, and by tetrapentylammonium ion, and was weakly inhibited by tetraethylammonium ion. Other K(+)-channel blockers, i.e. charybdotoxin, 4-aminopyridine and glybenclamide were ineffective. A monoclonal antibody (mAb 213-21) obtained by immunizing mice with the InsP3-sensitive membrane fraction from platelets also blocked Ca2+ release by InsP3 from membrane vesicles obtained from platelets, cerebellum, aortic smooth muscle, HEL cells and sea-urchin eggs. ATP-dependent Ca2+ uptake and binding of [3H]InsP3 to platelet membranes was unaffected by either K(+)-channel blockers or mAb 213-21. Blockade of Ca2+ release by apamin, tetrapentylammonium and mAb 213-21 was not affected by the Na+/H+ carrier monensin or the protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), but could be completely reversed by the K+/H+ ionophore nigericin and partially reversed by the K+ carrier valinomycin. The antibody-binding protein (ABP) solubilized from platelets, cerebellum, and smooth muscle chromatographed identically on gel filtration, anion-exchange and heparin-TSK h.p.l.c. ABP was purified to apparent homogeneity from platelets and aortic smooth muscle as a 63 kDa protein by immunoaffinity chromatography on mAb 213-21-agarose. These results suggest that optimal Ca2+ release by InsP3 from platelet membrane vesicles may require the tandem function of a K+ channel. A counterflow of K+ ions could prevent the build-up of a membrane potential (inside negative) that would tend to oppose Ca2+ release. The 63 kDa protein may function to regulate K+ permeability that is coupled to the Ca2+ efflux via the InsP3 receptor.
1,4,5-三磷酸肌醇(Ins(1,4,5)P3)诱导的血小板膜囊泡Ca2+释放被蜂毒明肽(一种低电导Ca(2+)-激活K+通道的选择性抑制剂)、四戊基铵离子所阻断,且被四乙铵离子微弱抑制。其他K+通道阻滞剂,如大蝎毒素、4-氨基吡啶和格列本脲则无效。用来自血小板的InsP3敏感膜组分免疫小鼠获得的单克隆抗体(mAb 213-21)也能阻断InsP3诱导的来自血小板、小脑、主动脉平滑肌、HEL细胞和海胆卵的膜囊泡的Ca2+释放。K+通道阻滞剂或mAb 213-21对ATP依赖的Ca2+摄取以及[3H]InsP3与血小板膜的结合均无影响。蜂毒明肽、四戊基铵和mAb 213-21对Ca2+释放的阻断不受Na+/H+载体莫能菌素或质子载体羰基氰对三氟甲氧基苯腙(FCCP)的影响,但可被K+/H+离子载体尼日利亚菌素完全逆转,并被K+载体缬氨霉素部分逆转。从小板、小脑和平滑肌中溶解的抗体结合蛋白(ABP)在凝胶过滤、阴离子交换和肝素-TSK高效液相色谱上的色谱行为相同。通过在mAb 213-21-琼脂糖上进行免疫亲和色谱,从血小板和主动脉平滑肌中纯化得到了表观均一的63 kDa的ABP。这些结果表明,InsP3从血小板膜囊泡中最佳释放Ca2+可能需要K+通道的串联功能。K+离子的逆流可以防止膜电位(内负)的积累,而膜电位的积累往往会阻碍Ca2+的释放。63 kDa的蛋白可能起到调节K+通透性的作用,该通透性通过InsP3受体与Ca2+外流相偶联。